Improving Tree-Based Lung Disease Classification from Chest X-Ray Images Using Deep Feature Representations.

Healthcare systems worldwide face increasing pressure to deliver accurate, affordable, and scalable diagnostic services while maintaining long-term sustainability. Chest X-ray screening is considered one of the most cost-effective methods for detecting lung disease. However, many deep learning approaches are computationally intensive and difficult to interpret, which limits their adoption in high-throughput, resource-constrained clinical settings. This study proposes a hybrid CNN-tree framework for automated lung disease classification from chest X-ray images, which targets COVID-19, pneumonia, tuberculosis, lung cancer, and normal cases. To ensure robustness and generalization, four publicly available chest X-ray datasets from different sources are merged into a unified five-class dataset, which introduces realistic variations in imaging conditions and patient populations. A ResNet-18 model is fine-tuned to extract domain-specific deep feature representations. Feature dimensionality and redundancy are reduced using Principal Component Analysis, while class imbalance is addressed through the Synthetic Minority Over-sampling Technique. The resulting compact feature vectors are used to train interpretable tree-based classifiers, which include Decision Tree, Random Forest, and XGBoost. Experiments conducted using five-fold stratified cross-validation demonstrate substantial and consistent performance gains. When trained on fine-tuned and preprocessed deep features, all evaluated tree-based classifiers achieve weighted F1-scores between 0.977 and 0.982 using five-fold cross-validation, with a significant reduction in inter-class confusion. In addition, the proposed framework maintains low per-sample inference latency, which supports energy-efficient and scalable deployment. These results indicate that combining deep feature learning with interpretable tree-based models provides a practical and reliable solution for sustainable chest X-ray screening in real-world clinical environments.